SCHEMBL2299116

SCHEMBL2299116

Fc1ccc(C2=C(c3ccncc3)NC(=S)[N]2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 16/20 0.42
GCGR P47871 5/20 0.41
MAPK13 O15264 4/20 0.40
MAPK12 P53778 4/20 0.40
MAPK11 Q15759 4/20 0.40
MAPK9 P45984 3/20 0.40
RAF1 P04049 2/20 0.40
MAPK10 P53779 2/20 0.39
PRKD3 O94806 2/20 0.39
MAP4K4 O95819 2/20 0.39
FRK P42685 2/20 0.39
CSNK1A1 P48729 2/20 0.39
CSNK1D P48730 2/20 0.39
GSK3B P49841 2/20 0.39
PTK6 Q13882 2/20 0.39
CLK4 Q9HAZ1 2/20 0.39
PRKD2 Q9BZL6 1/20 0.39
KDM4E B2RXH2 2/20 0.38
CIT O14578 1/20 0.38
GAK O14976 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2295783 0.82 MAPK14 (0.41) MAPK14MAPK13MAPK12MAPK11MAPK10
SCHEMBL6508399 0.80 MEN1 (0.38) MAPK14GCGRMAPK13MAPK12MAPK11
SCHEMBL464630 0.70 LMNA (0.65) MAPK14GCGRMAPK13MAPK12MAPK11
SCHEMBL6829472 0.70 LMNA (0.65) MAPK14GCGRMAPK13MAPK12MAPK11
SCHEMBL6112627 0.70 MAPK14 (0.55) MAPK14GCGRMAPK13MAPK12MAPK11
SCHEMBL1150867 0.67 MAPK14 (0.68) MAPK14GCGRMAPK13MAPK12MAPK11
SCHEMBL4285503 0.65 MAPK14 (0.48) MAPK14GCGRMAPK13MAPK12MAPK11
SCHEMBL6515232 0.64 MAPK14 (0.41) MAPK14MAPK13MAPK12MAPK11GSK3B
SCHEMBL1230814 0.62 MAPK14 (0.47) MAPK14GCGRMAPK13MAPK12MAPK11
SCHEMBL6337863 0.61 MAPK14 (0.60) MAPK14GCGRMAPK13MAPK12MAPK11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011100769-A2 KINASE MODULATORS FOR THE TREATMENT OF CANCER SYNOVO GMBH (DE) 2011-08-18 WO disclosed